在研究生第二年药房住院课程主任之间进行过渡的实用技巧
Kari Taggart1, Kyle Dvoracek2, Shanna K O'Connor3
1Avera McKennan Hospital and University Health Center, Sioux Falls, SD, USA.
概括
为药房住院计划主任 (RPDs) 制定了一个结构化的领导转型计划,以保持计划的质量. 成功的关键因素包括在交付过程中利用RPD专业知识和适应能力.
科学领域:
- 药房 教育 教育 药房 教育
- 领导力发展 领导力发展
- 医疗保健管理的管理
背景情况:
- 药房住院计划中的领导转型可能会影响计划的连续性和质量.
- 缺乏已确立的最佳实践,用于转移居留计划主任 (RPD) 角色.
研究的目的:
- 描述和评估在ASHP认证的课程中转换RPD角色的纵向过程.
- 建立RPD领导层继承的最佳实践.
主要方法:
- 一个系统的审查文件和材料从一个12个月的RPD过渡.
- 研究小组对过渡元素的基于共识的分类.
- 评估程序指标 (申请人数,评估及时性) 在过渡前,过渡期间和过渡后.
主要成果:
- 制定了详细的过渡时间表和任务列表.
- 节目质量指标保持稳定或有所改善.
- 申请人数量保持不变,及时评估增加,尽管最初的开发计划略有下降.
结论:
- 一个结构化的RPD过渡计划有助于节目质量维护和顺利的继承.
- 利用RPD特定技能和培养对调整的开放性对于成功的过渡至关重要.
相关概念视频
Drug Dosing: Geriatric Patients
281
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
281
IV Infusion to Oral Dosing: Conversion Methods
13
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
13
Discharge Summary Forms
1.3K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K
Dosage Regimens: Designs and Approaches
347
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
347
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
268
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
268


